|
⚲
|
| Keyboard |
| Dan Leslie
✚
|
|
|---|---|
| CIK # | 0001180551 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001180551] | |
| 4 | [0001180551] | |
| SC 13D | [0001180551] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Dan Leslie | Eleven Biotherapeutics Inc | [2016-09-28] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Dan Leslie | |
| Carisma Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Carisma Therapeutics Inc SESN
Stock Option · derivative
|
2019-06-19 | Grant | 52,500 | $0.00 | |
|
Carisma Therapeutics Inc SESN
Stock Option · derivative
|
2018-06-12 | Grant | 52,500 | $0.00 | |
|
Carisma Therapeutics Inc EBIO
Stock Option · derivative
|
2017-05-19 | Grant | 8,072 | $0.00 | |
|
Carisma Therapeutics Inc EBIO
Common Stock
|
2016-09-20 | Grant | 3,582,328 | ||
|
Carisma Therapeutics Inc EBIO
Stock Option · derivative
|
2016-09-20 | Grant | 16,143 | $0.00 |